Clinical trials: Atopic Eczema
Dermatitis, Atopic
A Study of an Eczema Spot Treatment in Providing Eczema Symptoms Relief and Lasting Itch Relief to Affected Skin Area
The purpose of this study is to evaluate the efficacy (assessed by clinical evaluation of eczema/atopic lesion severity [atopic dermatitis severity index {ADSI} scoring] and perceived benefits in itch [visual analog score {VAS}…
- Trial name
- NCT05226143
- Testing
- Gel Cream
- Where
- United States
- Volunteers
- 37 people
- Sponsor
- Johnson & Johnson Consumer Inc. (J&JCI)
Atopic Dermatitis (AD), SCORAD Index(15-25)
In-Use Tolerance & Efficacy Study Under Dermatological Control of Sunscreen in Adults With Atopic Dermatitis Skin
This study evaluates a broad-spectrum SPF50+ sunscreen on 42 adults with Atopic Dermatitis, measuring skin tolerance and barrier function.
- Trial name
- NCT07194421
- Testing
- Sunscreen RV4620A RP2552
- Where
- Mauritius
- Volunteers
- 42 people
- Sponsor
- Pierre Fabre Dermo Cosmetique
Atopic Dermatitis Eczema
Thykamine Safety and Efficacy Study in Mild-to-Moderate Atopic Dermatitis
A Phase 2, multicenter, double-blind, placebo control study evaluating the safety and efficacy of Thykamine in adult patient suffering of mild-to-moderate Atopic Dermatitis
- Trial name
- NCT03540043
- Testing
- Administration of PUR0110 (Thykamine) 0.05%, Administration of PUR0110 (Thykamine) 0.1%, Administration of PUR0110 (Thykamine) 0.25%
- Where
- 12 sites in Canada
- Volunteers
- 162 people
- Sponsor
- PurGenesis Technologies Inc.
Atopic Dermatitis
Tolerance and Efficacy of Formulation 609580 20 Versus Formulation 609209 in Children With Atopic Dermatitis
Atopic dermatitis is one of the most frequent skin diseases. The disease is often worst during winter months when the skin is drier. Mild to moderate cases of atopic dermatitis are often controlled by a moisturizer alone.
- Trial name
- NCT00931411
- Testing
- Formulation 609580 20, Formulation 609209 (Lipikar Baume)
- Where
- 5 sites in Canada
- Volunteers
- 73 people
- Sponsor
- Cosmetique Active International
Atopic Dermatitis
Efficacy and Safety Trial of ALK-depot SQ Mites in Subjects With Atopic Dermatitis
This trial is performed to assess the efficacy and safety of ALK-depot SQ mites for treatment of atopic dermatitis
- Trial name
- NCT00310492
- Testing
- subcutaneous immunotherapy
- Where
- Germany
- Volunteers
- 154 people
- Sponsor
- ALK-Abelló A/S
Mild to Moderate Atopic Dermatitis
CT 327 in the Treatment of Atopic Dermatitis
This study will look at how safe and effective, a novel agent, CT 327 cream is in treating patients with mild to moderate atopic dermatitis (AD).
- Trial name
- NCT00996008
- Testing
- CT 327
- Where
- 5 sites in Switzerland
- Volunteers
- 15 people
- Sponsor
- Creabilis SA